QT Prolongation and Torsade de Pointes Ventricular Tachycardia Produced by Ketanserin
- 1 November 1986
- journal article
- case report
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 9 (6) , 836-841
- https://doi.org/10.1111/j.1540-8159.1986.tb06633.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacology of Potent and Selective S2-Serotonergic AntagonistsJournal of Cardiovascular Pharmacology, 1985
- Hemodynamic Response to Chronic Ketanserin Treatment in Essential HypertensionJournal of Cardiovascular Pharmacology, 1985
- Serotonin and the HeartJournal of Cardiovascular Pharmacology, 1985
- Effect of Ketanserin on Blood Pressure and Biochemical Parameters in Patients with Essential HypertensionJournal of Cardiovascular Pharmacology, 1985
- Torsade de pointes due to quinidine: Observations in 31 patientsAmerican Heart Journal, 1984
- Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotilineThe American Journal of Cardiology, 1983
- Possible Female Preponderance in Prenylamine-Induced ‘Torsade de Pointes’ TachycardiaCardiology, 1983
- "Les Torsades de Pointes": An Unusual Ventricular ArrhythmiaAnnals of Internal Medicine, 1980
- Adrenergically Mediated Ventricular Fibrillation in Probucol‐Treated Dogs: Roles of Alpha and Beta Adrenergic ReceptorsPacing and Clinical Electrophysiology, 1979
- Electrocardiographic abnormalities induced by thioridazine (Mellaril)American Heart Journal, 1968